RUO Peptides Guide: BPC-157, TB-500, CJC-1295 for Research Labs | MedClinic Partners

IRB Research, RUO Peptides & Innovation

RUO Peptides: A Guide for Medical Practices and Research Labs

Research Use Only (RUO) peptides like BPC-157, TB-500, and CJC-1295 are available through licensed suppliers. Here is what RUO means, who can order, and what compliance looks like.

M
MedClinic Partners Editorial TeamB2B Medical Supply & Compounding Experts
4 min read
Reviewed & updated:
RUO Peptides: A Guide for Medical Practices and Research Labs — MedClinic Partners

RUO Peptides: A Guide for Medical Practices and Research Labs

Research Use Only (RUO) peptides occupy a distinct regulatory category that is often misunderstood. For medical practices and research laboratories that want to access high-purity peptides like BPC-157, TB-500, CJC-1295/Ipamorelin, PT-141, Sermorelin, and Epithalon, understanding the RUO framework is essential.

This post explains what RUO means, who can order RUO peptides, and what compliance looks like for practices and labs that work with these compounds.

What Does "Research Use Only" Mean?

Research Use Only (RUO) is a regulatory designation that indicates a product is intended strictly for laboratory and research purposes. RUO products:

  • Are not intended for human consumption or therapeutic use
  • Are not intended for diagnosis or clinical application
  • Are not FDA-approved as drugs or medical devices
  • Are not subject to the same regulatory requirements as pharmaceutical products

The RUO designation is a statement of intended use — it does not mean the compounds are unregulated in all respects, but it does mean they operate under a different regulatory framework than compounded medications.

Who Can Order RUO Peptides?

RUO peptides are available to:

  • Licensed research laboratories conducting legitimate scientific research
  • Academic institutions with appropriate research programs
  • Medical practices with research programs that have appropriate oversight
  • IRB-enrolled studies where the research protocol has been reviewed and approved

The key requirement is that the purchaser has a legitimate research purpose and is operating within the appropriate legal and ethical framework for research.

Important: RUO peptides are entirely separate from the 503A compounded GLP program. They are not interchangeable, and they are not a workaround for obtaining therapeutic compounds.

The RUO Peptides We Supply

Our RUO catalog includes high-purity peptides commonly used in research settings:

BPC-157 (Body Protection Compound)

One of the most extensively researched peptides for tissue repair and recovery mechanisms. Available as lyophilized powder and injectable solution. Purity ≥99%.

TB-500 (Thymosin Beta-4)

A synthetic version of Thymosin Beta-4, studied for its role in cell migration, differentiation, and tissue repair. Available as lyophilized powder. Purity ≥99%.

CJC-1295/Ipamorelin

A combination of a GHRH analog (CJC-1295) and a ghrelin mimetic (Ipamorelin), studied for effects on growth hormone secretion. Available as lyophilized powder. Purity ≥99%.

PT-141 (Bremelanotide)

A melanocortin receptor agonist studied for effects on sexual function. Available as lyophilized powder. Purity ≥99%.

Sermorelin

A GHRH analog studied for effects on growth hormone secretion. Available as lyophilized powder. Purity ≥99%.

Epithalon (Epitalon)

A tetrapeptide studied for effects on telomerase activity and cellular aging. Available as lyophilized powder. Purity ≥99%.

Quality Standards for RUO Peptides

Not all RUO peptide suppliers are equal. Quality matters significantly for research validity and safety. Our RUO peptides meet the following standards:

Purity: ≥99% purity confirmed by HPLC analysis

Certificate of Analysis: COA provided with every lot, including purity testing, identity confirmation, and endotoxin testing where applicable

USA-Manufactured: All RUO peptides are manufactured in the United States

Proper Labeling: All products are clearly labeled as "Research Use Only — Not for Human Use"

Compliance Requirements for RUO Purchasers

If you are a medical practice or research lab ordering RUO peptides, here is what compliance looks like:

Documentation

Maintain documentation of your research purpose, including:

  • Research protocol or study design
  • IRB approval (if applicable)
  • Institutional authorization (if applicable)
  • Records of how the compounds are used

Proper Storage and Handling

RUO peptides must be stored and handled in accordance with their specifications. Most lyophilized peptides require refrigeration or freezing.

No Human Administration

RUO peptides cannot be administered to humans. This is not a technicality — it is a fundamental legal and ethical requirement. Practices that administer RUO compounds to patients are operating outside the law.

Separate from Clinical Operations

RUO compounds must be kept separate from clinical supplies and must not be accessible to clinical staff for patient use.

IRB Enrollment: The Path to Research Administration

If your practice is interested in studying peptides in a human research context, IRB (Institutional Review Board) enrollment is the appropriate pathway. An IRB-approved study provides the ethical and regulatory framework for human research.

At MedClinic Partners, we have an IRB enrollment program for qualified providers. Contact us for information.

Contact us about RUO peptides or IRB enrollment →

All RUO peptides are intended strictly for laboratory and research purposes only. They are not intended for human consumption, therapeutic use, diagnosis, or clinical application. Purchasers are solely responsible for compliance with all applicable laws and regulations.

Explore Topics

#RUO#peptides#BPC-157#TB-500#research#compliance
M

Written by

MedClinic Partners Editorial Team

B2B Medical Supply & Compounding Experts

The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.

503A/503B CompoundingGLP-1 ProtocolsRegulatory ComplianceMedical Practice Operations

Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.

For Licensed Providers

Ready to access 503A/503B supply + peptides?

Submit your info and we'll help connect you with the right compounding and research peptide partners for your practice.